Investigation of CYP2D6 Gene Polymorphisms in Turkish Population

about

Investigation of CYP2D6 Gene Polymorphisms in Turkish Population

Item

http://www.wikidata.org/entity/Q37299922

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Investigation of CYP2D6 Gene Polymorphisms in Turkish Population

@en

Investigation of CYP2D6 Gene Polymorphisms in Turkish Population.

@nl

type

Item

label

Investigation of CYP2D6 Gene Polymorphisms in Turkish Population

@en

Investigation of CYP2D6 Gene Polymorphisms in Turkish Population.

@nl

prefLabel

Investigation of CYP2D6 Gene Polymorphisms in Turkish Population

@en

Investigation of CYP2D6 Gene Polymorphisms in Turkish Population.

@nl

P1476

Investigation of CYP2D6 Gene Polymorphisms in Turkish Population

@en

P2093

Bayram Taskin

http://www.w3.org/2001/XMLSchema#string

Ferda E Percin

http://www.w3.org/2001/XMLSchema#string

Mehmet Ali Ergun

http://www.w3.org/2001/XMLSchema#string

P2860

Expression and functional analysis of CYP2D6.24, CYP2D6.26, CYP2D6.27, and CYP2D7 isozymes

Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes.

Pharmacogenetics and adverse drug reactions.

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.

Pharmacogenomics of CYP2D6: molecular genetics, interethnic differences and clinical importance.

S-mephenytoin, sparteine and debrisoquine oxidation: genetic polymorphisms in a Turkish population.

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.

A review and assessment of potential sources of ethnic differences in drug responsiveness.

P304

67-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27738374

http://www.w3.org/2001/XMLSchema#string

P932

5044487

http://www.w3.org/2001/XMLSchema#string